APA (7th ed.) Citation

Morita-Fujita, M., Arai, Y., Yoshioka, S., Ishikawa, T., Kanda, J., Kondo, T., . . . Takaori-Kondo, A. (2020). Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies. Scientific reports, 10(1), 21418-8. https://doi.org/10.1038/s41598-020-78334-x

Chicago Style (17th ed.) Citation

Morita-Fujita, Mari, et al. "Indication and Benefit of Upfront Hematopoietic Stem Cell Transplantation for T-cell Lymphoblastic Lymphoma in the Era of ALL-type Induction Therapies." Scientific Reports 10, no. 1 (2020): 21418-8. https://doi.org/10.1038/s41598-020-78334-x.

MLA (9th ed.) Citation

Morita-Fujita, Mari, et al. "Indication and Benefit of Upfront Hematopoietic Stem Cell Transplantation for T-cell Lymphoblastic Lymphoma in the Era of ALL-type Induction Therapies." Scientific Reports, vol. 10, no. 1, 2020, pp. 21418-8, https://doi.org/10.1038/s41598-020-78334-x.